Pharmaceutical formulations
US10166183B2 · kind B2 · utility
20Cited by
18References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 5, 2015 |
| Grant date | Jan 1, 2019 |
| Priority date | — |
| Expiry date | Feb 5, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to new extended release pharmaceutical compositions and methods of use thereof for the treatment of disorders. In certain embodiments, disclosed herein is an extended-release pharmaceutical formulation comprising, in a solid dosage form for oral delivery of between about 100 mg and about 1 g total weight: between about 2 and about 18% of an active ingredient; between about 70% and about 96% of one or more diluents; between about 1% and about 10% of a water-soluble binder and between about 0.5 and about 2% of a surfactant.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.